HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Schering AG

Division of Bayer AG

Latest From Schering AG

Appointments: Avillion, X4 Pharmaceuticals, Summit, Cytovation, Kymab, Ipsen and Sosei

This week's roundup includes the appointments of chief medical officers by both Avillion and X4 Pharmaceuticals and various other senior appointments at Summit Therapeutics, Sosei, Ipsen and Kymab.

Appointments BioPharmaceutical

Appointments: Gilead, Biogen, Nordic Nanovector, Neon Therapeutics, Achaogen and vasopharm

This week's roundup includes executive appointments by Gilead Sciences, Nordic Nanovector, Mereo BioPharma, vasopharm and Rigontec. Biogen has also appointed two executives to its planned spin-off company, Bioverativ.


Asia On The Move: Nichi-Iko Names Outsider To Lead Sagent

November has brought a flurry of senior level pharma executive changes in the Asia Pacific region.

Appointments Asia Pacific

Renova’s Gene Therapy To Reverse Heart Remodeling In CHF

Reversing the “remodeling” of the heart in congestive heart failure with an investigational gene therapy is one of the aims of the San Diego-based biotech that is planning late-stage clinical development.

BioPharmaceutical Clinical Trials
See All

Company Information